URL Insurance Group.
Medicare Offerings

November 10, 2017

 

 

IN THIS ISSUE

Great News for Members with Diabetes

 


Save big on long-acting insulin in 2018

SilverScript is helping to reduce costs in 2018 for members who receive treatment for diabetes.

Three long-acting injectable insulin products will be on the 2018 Choice formulary as Tier 2 drugs, representing a nearly 60% savings over 2017 pricing on a 30-day supply when filled at a Choice Preferred Network Pharmacy.1 Members can save even more by choosing 90-day supplies. Three months of insulin will cost less than $50 – essentially providing members with a 90-day supply for the same or less than what they currently pay for a 30-day supply of a similar medication.

Medicare beneficiaries should speak with their doctors to determine which of these lower cost alternatives might be right for them:

  • Basaglar® (prefilled pen injectors)
  • Levemir® (prefilled pen injectors or vials)
  • Tresiba® (prefilled pen injectors)

These three long-acting insulins will replace Lantus and Toujeo, which will no longer be on the SilverScript Choice formulary for 2018. (Lantus and Toujeo will still be available on the SilverScript Plus formulary.) Choice Members will need a new prescription from their doctors to switch to a new drug. Be sure they ask for a prescription written for 90-day supplies, and use a Preferred Network Pharmacy to maximize the savings.

Details about the lower copay insulins

 

 

With healthcare costs continuing to rise, SilverScript remains committed to providing ways to reduce prescription drug costs for our members.

 

Options For SilverScript Choice Members on Lantus

For clients who have discussed options with their physician and still have questions about considering an alternative to Lantus:

  • Each alternative insulin has been approved by the Federal Drug Administration (FDA) and proven to lower blood sugar as effectively as Lantus. 
  • Basaglar is the same amino acid sequence as Lantus and is a Follow-on Biologic, manufactured by a different pharmaceutical company.

For clients who do not wish to switch from Lantus or Toujeo, consider SilverScript Plus.

  • Lantus and Toujeo are available as Tier 3 drugs on the 2018 SilverScript Plus Formulary.
  • SilverScript Plus premiums are lower in 2018 and may provide a cost-effective option for clients who want to continue taking Lantus or Toujeo.

 

 

 


Quick Link:

www.SilverScriptAgentPortal.com

Questions or comments? Please contact your upline admin team. They are ready to support you.

1 60% Savings based on cost for 30-day supply of a Tier 3 drug in 2017 vs. cost for 30-day supply of a Tier 2 drug in 2018 obtained through a Choice Preferred Network Pharmacy in the Initial Coverage Stage. Savings may vary by region and for members receiving Extra Help.

 

FOR AGENT USE ONLY and not intended for public or general use.

 

CONFIDENTIALITY NOTICE: This communication and any attachments may contain confidential and/or proprietary information for the use of the designated recipients named above. If you are not the intended recipient, you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or its contents is prohibited. If you have received this communication in error, please notify the sender immediately by telephone and destroy all copies of this communication and any attachments.

 

AgentID/Name/Type/Status/2018T: KClemensURL/Kenneth Clemens/Super NMO Admin/passed

This document contains references to brand-name prescription drugs that are trademarks or registered trademarks of pharmaceutical manufacturers not affiliated with CVS Caremark.

 

©2017 CVS Caremark. All rights reserved. CVS Caremark Confidential Information.
This presentation contains CVS Caremark Confidential Information and cannot be used, reproduced, distributed or printed without written permission from CVS Caremark.